Statistik Asas
| LEI | 549300OZV3WLQQWOD724 |
| CIK | 1676047 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Nutriband Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| September 3, 2025 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2025 Nutriband Inc. |
|
| August 7, 2025 |
Exhibit 3.1d ATTACHMENT CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES FOR THE SERIES A CONVERTIBLE PREFERRED STOCK OF NUTRIBAND INC. The undersigned, the Chief Executive Officer of Nutriband Inc., a Nevada corporation (“Nutriband”) or (the "Company"), in accordance with the provisions of Section 1955, Chapter 78 Nevada Statutes, does hereby certify that, pursuant to the authority conferred |
|
| August 7, 2025 |
CERTIFICATE OF CORRECTION FILED JULY 21, 2025 Exhibit 3.1e EXHIBIT 3.1E TYPE OR PRINT - U9E DARK INK ONLY DO NOT HIGHLIGHT IN9TRUCTION9: t. Enter the current name as on file with the Nevada Secretary of State and enter the Entity or Nevada Business Identification Number (NVID). 2. Name of document with inaccuracy or defect. 3. Filing date of document with inaccuracy or defect. 4. Brief description of inaccuracy or defect. 5. Correction of ina |
|
| August 7, 2025 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); August 5, 2025 Nutriband Inc. |
|
| July 16, 2025 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); July 14 2025 Nutriband Inc. |
|
| July 16, 2025 |
Exhibit 3.1d SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8 - K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); July 14 2025 Nutriband Inc. Nevada 000 - 40854 (State or Other Jurisdiction (Commission File Number) of Incorporation) 81 - 1118176 (I.R.S. Employer Identification No.) 121 S. Orange A |
|
| July 8, 2025 |
Filed Pursuant to Rule 424(b)(4) Registration No. 333-259833 PROSPECTUS Warrants to Purchase 957,980 Shares of Common Stock Nutriband Inc. Nasdaq trading symbol for the common stock: NTRB This prospectus covers the issuance by Nutriband Inc. (the “Company”) of 957,980 shares of common stock, par value $0.001 per share (“common stock”)’ upon the exercise of warrants (the “Warrants”), issued in a pu |
|
| July 3, 2025 |
As filed with the Securities and Exchange Commission on July 3, 2025 As filed with the Securities and Exchange Commission on July 3, 2025 Registration No. |
|
| June 23, 2025 |
COMMERCIAL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT Exhibit 10.35 COMMERCIAL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT This Commercial Development and Clinical Supply Agreement (“Agreement”) is made on January 4, 2023 (“Effective Date”). BETWEEN: (1) 4P Therapeutics LLC, a Delaware limited liability company with principal address at P.O. Box 921031, Peachtree Corners, GA 30010-1031 (“4P”); and (2) Kindeva Drug Delivery L.P., a Delaware limited part |
|
| June 23, 2025 |
As filed with the Securities and Exchange Commission on June 20, 2025 As filed with the Securities and Exchange Commission on June 20, 2025 Registration No. |
|
| June 23, 2025 |
[signatures to follow on next page] Exhibit 10.36 AMENDMENT NO. 1, dated as of February 4, 2025 (this “Amendment”), to the COMMERCIAL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT, made as of January 4, 2024 (the “Agreement”), is by and between Kindeva Drug Delivery LP., a Delaware limited partnership with principal address at 11200 Hudson Road, Woodbury, MN 55129 (“KINDEVA”) and 4P Therapeutics LLC, a Delaware limited liability company |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| May 13, 2025 |
NUTRIBAND, INC. CLAWBACK POLICY (Effective October 3, 2023) Exhibit 97.1 NUTRIBAND, INC. CLAWBACK POLICY (Effective October 3, 2023) Purpose The Board of Directors (the “Board”) of Nutriband Inc., a Nevada corporation (together with its subsidiaries, the “Company”), has adopted this policy to ensure that executive officers do not retain the benefits of certain erroneously awarded compensation and also to further incent conduct intended to improve the overa |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2025 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. |
|
| April 28, 2025 |
Exhibit 10.35 COMMERCIAL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT This Commercial Development and Clinical Supply Agreement (“Agreement”) is made on January 4, 2023 (“Effective Date”). BETWEEN: (1) 4P Therapeutics LLC, a Delaware limited liability company with principal address at P.O. Box 921031, Peachtree Corners, GA 30010-1031 (“4P”); and (2) Kindeva Drug Delivery L.P., a Delaware limited part |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2025 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. (Exact name of reg |
|
| April 28, 2025 |
Exhibit 10.36 AMENDMENT NO. 1, dated as of February 4, 2025 (this “Amendment”), to the COMMERCIAL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT, made as of January 4, 2024 (the “Agreement”), is by and between Kindeva Drug Delivery LP., a Delaware limited partnership with principal address at 11200 Hudson Road, Woodbury, MN 55129 (“KINDEVA”) and 4P Therapeutics LLC, a Delaware limited liability company |
|
| April 9, 2025 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); April 4, 2025 Nutriband Inc. |
|
| April 9, 2025 |
Nutriband Signs Associate Partnership With Charlotte FC Exhibit 99.1 Nutriband Signs Associate Partnership With Charlotte FC ORLANDO, FL / ACCESSWIRE / April 4, 2025 / Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with Charlotte FC. The Company intends to use the Associate Partnership to build visibility for its brands |
|
| February 13, 2025 |
Exhibit 99.1 Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with Kindeva Drug Delivery to develop Aversa™ Fentanyl which combines Nutriband’s Aversa™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. ORLANDO, Fla., Feb. 13, 2025 (GLOB |
|
| February 13, 2025 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); February 13, 2025 Nutriband Inc. |
|
| February 12, 2025 |
Exhibit 99.1 Nutriband Receives Notice of Allowance fOR NEW U.S. PATENT COVERING ITS Transdermal Abuse Deterrent Technology The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents issued in 46 countries including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia. ORLANDO, FL / ACCESSWI |
|
| February 12, 2025 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); February 7, 2025 Nutriband Inc. |
|
| January 29, 2025 |
Submission of Matters to a Vote of Security Holders SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 23, 2025 Nutriband, Inc. |
|
| December 30, 2024 |
NUTRIBAND EXTENDS CHINESE PATENT TO MACAO FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY Exhibit 99.1 NUTRIBAND EXTENDS CHINESE PATENT TO MACAO FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY Nutriband’s abuse-deterrent platform technology is now patented in 46 countries and territories covering major global markets. Nutriband is targeting to file for FDA approval for AVERSA™ Fentanyl in the first half of 2025. ORLANDO, FL / ACCESSWIRE / December 27, 2024 / Nutriband Inc. (NASD |
|
| December 30, 2024 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); December 27, 2024 Nutriband Inc. |
|
| December 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40854 NUTRIBAND INC. (Exact nam |
|
| October 31, 2024 |
EXHIBIT 99.1 Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the Chinese National Intellectual Property Administrant (CNIPA) has fully issued its patent titled "Abuse and Misuse Det |
|
| October 31, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported); October 31, 2024 Nutriband Inc. |
|
| September 19, 2024 |
SC 13D/A 1 ea0207317-13da1tiijetnutri.htm AMENDMENT NO. 1 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) NUTRIBAND INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 67092M208 (CUSIP Number) Tel: (407) 377-6695 (Name, Address and Telephone Number of Person Au |
|
| September 18, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 16, 2024 Nutriband Inc. |
|
| September 18, 2024 |
Nutriband Inc. Announces $1 Million Share Buyback Program EXHIBIT 99.1 Nutriband Inc. Announces $1 Million Share Buyback Program ORLANDO, Fla., Sept 16, 2024 – Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of September 16, 2024, the Company had 11,106,185 shares of common stock outstanding. Progress continues on the development of AVERSA Fentanyl, with the Comp |
|
| September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name o |
|
| July 26, 2024 |
Filed Pursuant to Rule 424(b)4 Registration 333-259833 PROSPECTUS Warrants to Purchase 959,005 Shares of Common Stock Nutriband Inc. |
|
| July 23, 2024 |
As filed with the Securities and Exchange Commission on July 22, 2024 As filed with the Securities and Exchange Commission on July 22, 2024 Registration No. |
|
| July 5, 2024 |
As filed with the Securities and Exchange Commission on July 3, 2024 As filed with the Securities and Exchange Commission on July 3, 2024 Registration No. |
|
| June 3, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2024 Nutriband Inc. |
|
| June 3, 2024 |
Amendment to Note Conversion Agreement dated May 13, 202421 Exhibit 10.34 AMENDMENT TO NOTE CONVERSION AGREEMENT Dated: May 22, 2024 Gentlemen: In this amendment (the “Amendment”), undersigned holder (the “Holder”) and Nutriband Inc. (the “Corporation”), which are collectively referred to herein as the “Parties”, agree to amend the Note Conversion Agreement dated May 14, 2024 (the “Agreement”) between the Parties to provide for the modification of the secu |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| May 21, 2024 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2024 Nutriband Inc. |
|
| May 21, 2024 |
Form of Note Conversion Agreement dated May 13, 202420 Exhibit 10.33 NOTE CONVERSION AGREEMENT Dated: May 14, 2024 Gentlemen: The undersigned holder (the “Holder”) agrees to convert (the “Conversion) the outstanding $300,000 of principal and accrued interest outstanding on that amount as of May 14, 2024, of the Credit Line Promissory Note of Nutriband Inc., a Nevada corporation (the “Corporation”), held by Holder (the “Note”), into 76,230 shares of Co |
|
| May 17, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2024 Nutriband Inc. |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. (Exact name of reg |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING (CHECK ONE): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ N-CSR For Period Ended: January 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form |
|
| April 23, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 19, 2024 Nutriband Inc. |
|
| April 23, 2024 |
Form of Common Stock Purchase Warrant issued in 2024 Equity Financing (18) EXHIBIT 4.19 NEITHER THIS WARRANT NOR THE WARRANT SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS. NEITHER THIS WARRANT NOR THE SHARES OF WARRANT STOCK ISSUABLE UPO |
|
| April 23, 2024 |
Form of Subscription Agreement for April 19, 2024 Equity Financing (19) EXHIBIT 10.32 Nutriband Inc. SUBSCRIPTION AGREEMENT Nutriband Inc. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 Ladies and Gentlemen: The offer and sale of shares of common stock, par value $0.001 per share, of Nutriband Inc., a Nevada corporation (the "Company"), and warrants to purchase common stock with an exercise price of $6.43 and expiring five years from the date of issuance in |
|
| March 28, 2024 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 20, 2024 Nutriband Inc. |
|
| March 28, 2024 |
2024 Amended and Restated Stock Option Plan, adopted March 20, 2024.(15) Exhibit 4.16 NUTRIBAND INC. EMPLOYEE STOCK OPTION PLAN (Amended and Restated March 20, 2024) This AMENDED AND RESTATED STOCK OPTION PLAN (the “Plan”) is hereby established by NUTRIBAND INC., a Nevada corporation (the “Corporation”), the Plan having been originally adopted by the Company’s Board of Directors on October 29, 2021 and approved by its stockholders as of the 21st day of January, 2022, a |
|
| February 13, 2024 |
US67092M2089 / Nutriband Inc / MELNIK SERGUEI - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* NUTRIBAND INC. (Name of Issuer) Common Stock (Title of Class of Securities) 67092M208 (CUSIP Number) February 15, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 12, 2024 |
US67092M2089 / Nutriband Inc / Sheridan Gareth - SCHEDULE 13G Passive Investment SC 13G 1 ea193360-13gsherinutriband.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* NUTRIBAND INC. (Name of Issuer) Common Stock (Title of Class of Securities) 67092M208 (CUSIP Number) February 15, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| January 25, 2024 |
Submission of Matters to a Vote of Security Holders SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 21, 2024 Nutriband, Inc. |
|
| January 23, 2024 |
US67092M2089 / Nutriband Inc / T.I.I. - JETSERVICES, LDA - SCHEDULE 13D Activist Investment SC 13D 1 ea191987-13dtiijetnutriband.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a) NUTRIBAND INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 670 |
|
| January 11, 2024 |
Exhibit 99.1 NUTRIBAND SIGNS COMMERCIAL DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT WITH KINDEVA DRUG DELIVERY FOR AVERSA™ FENTANYL, AN ABUSE DETERRENT FENTANYL PATCH ORLANDO, FL / ACCESSWIRE / January 4, 2024 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today announced it has signed a commercial development and clinical |
|
| January 11, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2024 Nutriband Inc. |
|
| December 29, 2023 |
Conversion Agreement, dated December 19, 2023.(17) Exhibit 10.31 NOTE CONVERSION AGREEMENT Dated: December 19, 2023 Gentlemen: The undersigned holder (the “Holder”) agrees to convert (the ”Conversion) $2,000,000 of the outstanding principal and accrued interest outstanding as of December 19, 2023, of the Creditline Promissory Note of Nutriband Inc., a Nevada corporation (the “Corporation”), held by Holder, as amended and restated as of July 13, 20 |
|
| December 29, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2023 Nutriband Inc. |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| December 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact nam |
|
| September 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name o |
|
| July 19, 2023 |
Nutriband Inc. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 Nutriband Inc. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 July 19, 2023 Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: Nutriband Inc. Rule 477 Application for Withdrawal Registration Statement on Form S-1 Filed January 19, 2013 File No. 333-271791 Dear Sir/Madam: Pursuant |
|
| July 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2023 Nutriband Inc. |
|
| July 14, 2023 |
Nutriband Inc. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 Nutriband Inc. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 July 14, 2023 Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: Nutriband Inc. Rule 477 Application for Withdrawal Registration Statement on Form S-1 Filed January 19, 2013 File No. 333-271791 Dear Sir/Madam: Pursuant |
|
| July 14, 2023 |
Creditline Promissory Note, dated July 13, 2023. (16) EXHIBIT 10.30 CREDITLINE PROMISSORY NOTE (Amended and Restated as of July 13, 2023) Dated: July 13, 2023 FOR VALUE RECEIVED, on July 13, 2023, the undersigned Nutriband Inc., 121 South Orange Street, Suite 1500, Orlando, Florida 32801(“Borrower”), promises to pay to the order of TII JET SERVICES,LDA, or order (“Lender”), with offices at Rua das Ladeiras 5, Porto Santo, 9400-131 Portugal, the princ |
|
| July 6, 2023 |
As filed with the Securities and Exchange Commission on July 6, 2023 As filed with the Securities and Exchange Commission on July 6, 2023 Registration No. |
|
| June 26, 2023 |
Form of Underwriting Agreement. Exhibit 1.1 NUTRIBAND INC. UNDERWRITING AGREEMENT June [●], 2023 Joseph Gunnar & Co., LLC 40 Wall Street, 30th Floor New York, NY 10005 Representative of the Underwriters As named on Schedule I hereto Ladies and Gentlemen: The undersigned, Nutriband Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as |
|
| June 26, 2023 |
As filed with the Securities and Exchange Commission on June 23, 2023 As filed with the Securities and Exchange Commission on June 23, 2023 Registration No. |
|
| June 26, 2023 |
Form of Warrant issued to the Representative.(14) Exhibit 4.17 FORM OF REPRESENTATIVE WARRANT AGREEMENT NUTRIBAND INC. THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT THIS WARRANT SHALL NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THE SECURITIES FOR A PERIOD OF O |
|
| June 26, 2023 |
List of Subsidiaries of Nutriband Inc.(14) Exhibit 21.1 Subsidiaries of Registrant. Name of Subsidiary Jurisdiction of Incorporation 4P Therapeutics LLC Georgia Pocono Pharmaceuticals Inc. Delaware |
|
| June 21, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2023 Nutriband Inc. |
|
| June 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| June 9, 2023 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 June 9, 2023 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 June 9, 2023 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated May 31, 2023 Form 8-K Filed January 5, 2023 File No. 333-237724 Dear Sir/Madam: Please find below one change to the responses filed May 31, 2023 to the questions raised by the staff of the Securities and Exchange |
|
| May 31, 2023 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 31, 2023 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 31, 2023 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated May 31, 2023 Form 8-K Filed January 5, 2023 File No. 333-237724 Dear Sir/Madam: Please find below responses to certain questions raised by the staff of the Securities and Exchange Commission in its letter dated Ma |
|
| May 25, 2023 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 25, 2023 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 25, 2023 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated March 24, 2023 Form 8-K Filed January 5, 2023 File No. 333-237724 Dear Sir/Madam: This letter is to supplement the comment response filed on April 6, 2023, by the Company to the Commission’s comment letter dated F |
|
| May 12, 2023 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 11, 2023 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 11, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 RE: Nutriband Inc. Registration Statement on Form S-1 File No. 333-271791 To Whom It May Concern: Reference is made to the Registration Statement on Form S-1 (File No. 333-271791) filed by Nutr |
|
| May 10, 2023 |
As filed with the Securities and Exchange Commission on May 10, 2023 As filed with the Securities and Exchange Commission on May 10, 2023 Registration No. |
|
| May 10, 2023 |
Exhibit 107 Calculation of Filing Fee Tables S-1 ………….. (Form Type) ………………………Nutriband Inc.…………………………….. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price (1) (2) Fee Rate Amo |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. (Exact name of reg |
|
| April 6, 2023 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 April 6, 2023 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 April 6, 2023 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated March 24, 2023 Form 8-K Filed January 5, 2023 File No. 333-237724 Dear Sir/Madam: Please find below responses to certain questions raised by the staff of the Securities and Exchange Commission in its letter dated |
|
| March 29, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2023 Nutriband Inc. |
|
| March 29, 2023 |
EXHIBIT 99.1 Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA™ Abuse-Deterrent Transdermal Technology ORLANDO, Fla., March 28, 2023 – Nutriband Inc. (“Company”) (NASDAQ:NTRB) (NASDAQ:NTRBW) has entered into a three-year $2,000,000 Credit Line facility to provide financing through the FDA approval process into commercial scale manufacturing f |
|
| February 27, 2023 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 February 27, 2023 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 February 27, 2023 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated February 13, 2023 Form 8-K Filed January 5, 2023 File No. 333-237724 Dear Sir/Madam: Please find below responses to certain questions raised by the staff of the Securities and Exchange Commission in its lette |
|
| January 5, 2023 |
EXHIBIT 99.1 Nutriband Inc. Commences Trading on Upstream Under NTRB Nutriband among the first issuers to dual list on Upstream ORLANDO, FL ACCESSWIRE / January 5, 2023 / Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), a pioneer in the science of using novel transdermal solutions and other innovative technologies, will become available today at 10:00am EST under the ticker symbol NTRB on Upstream, |
|
| January 5, 2023 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2023 Nutriband Inc. |
|
| December 30, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 9, 2022 Nutriband, Inc. |
|
| December 30, 2022 |
424B3 1 ea170957-424b3nutriband.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(3) Registration No. 333-259833 PROSPECTUS SUPPLEMENT No. 2 December 30, 2022 (To Prospectus dated July 8, 2022) NUTRIBAND INC. 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock On October 5, 2021, the Company consummated a public offering of 1,056, |
|
| December 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact nam |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| October 12, 2022 |
As filed with the Securities and Exchange Commission on October 11, 2022 S-8 POS 1 ea166958-s8posnutribandinc.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on October 11, 2022 Registration No. 333-260842 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nutriband Inc. (Exact name of registrant as |
|
| October 6, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-259833 PROSPECTUS SUPPLEMENT No. 1 October 6, 2022 (To Prospectus dated July 8, 2022) NUTRIBAND INC. 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock On October 5, 2021, the Company consummated a public offering of 1,056,00 Units, at $6.25 per Unit, each Unit consisting of one sha |
|
| October 6, 2022 |
Nutriband Inc. Announces Application for Dual Listing on Upstream Exhibit 99.1 Nutriband Inc. Announces Application for Dual Listing on Upstream ORLANDO, Fla., Oct 3, 2022? Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW) (?Nutriband? or the ?Company?) today announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex (?Horizon?) and MERJ Exchange Limi |
|
| October 6, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits United States SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2022 Nutriband Inc. |
|
| September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name o |
|
| August 19, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2022 Nutriband Inc. |
|
| August 10, 2022 |
Nutriband Inc. Details of Seven-for-Six Forward Stock Split. EXHIBIT 99.1 Nutriband Inc. Details of Seven-for-Six Forward Stock Split. ORLANDO, Fla., August 10, 2022 ? Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW) (?Nutriband? or the ?Company?) announced on July 27, 2022 that its Board of Directors had approved and declared a 7:6 forward split of its common stock with a record date of Monday, August 15, 2022 (the ?Stock Split?). Each shareholder of record as |
|
| August 10, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 Nutriband Inc. |
|
| August 10, 2022 |
Certificate of Change, filed with the Nevada Secretary of State on August 4, 2022.(13) EXHIBIT 3.1C |
|
| August 1, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2022 Nutriband Inc. |
|
| August 1, 2022 |
Exhibit 99.1 Nutriband Receives Notice of Allowance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent ORLANDO, Fla., August 1, 2022 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office (CIPO) for its patent application, CA 2937649, entitled “ |
|
| July 27, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2022 Nutriband Inc. |
|
| July 27, 2022 |
Nutriband Inc. Announces Seven-for-Six Forward Stock Split. Exhibit 99.1 Nutriband Inc. Announces Seven-for-Six Forward Stock Split. ORLANDO, Fla., July 27, 2022? Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW) (?Nutriband? or the ?Company?) announced today that its Board of Directors has approved and declared a 7:6 forward split of its common stock that is expected to be effective at 12:01AM on August 15 and in effect at the opening of trading on Monday Augu |
|
| July 26, 2022 |
EXHIBIT 99.1 1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in favor of the Company. ORLANDO, Fla., July 26, 2022 ? Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has received the Final Judgment in favor of the company, effectively allowing the company to cancel 1.2M shares held by the defendants in the Court case f |
|
| July 26, 2022 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2022 Nutriband Inc. |
|
| July 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2022 Nutriband Inc. |
|
| July 15, 2022 |
Exhibit 99.1 Nutriband Inc. Successfully obtains court verdict for recovery of shares constituting 15% of its total outstanding shares. ORLANDO, Fla., July 15, 2022 ? Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has received a verdict in favor of the company, where the company prevailed on all issues, relating to the lawsuit the company filed to rescind the acquisition of |
|
| July 8, 2022 |
Filed Pursuant to Rule 424(b)4 Registration 333-259833 PROSPECTUS 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock Nutriband Inc. |
|
| June 29, 2022 |
As filed with the Securities and Exchange Commission on June 28, 2022 Registration No. |
|
| June 17, 2022 |
As filed with the Securities and Exchange Commission on June 17, 2022 As filed with the Securities and Exchange Commission on June 17, 2022 Registration No. |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| May 16, 2022 |
As filed with the Securities and Exchange Commission on May 13, 2022 As filed with the Securities and Exchange Commission on May 13, 2022 Registration No. |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2022 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. (Exact name of reg |
|
| February 28, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-259833 PROSPECTUS SUPPLEMENT No. 4 February 28, 2022 (To Prospectus dated October 1, 2021) NUTRIBAND INC. 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock This prospectus supplement further supplements and updates the prospectus dated October 1, 2021, relating to our offering thro |
|
| January 31, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2022 Nutriband, Inc. |
|
| January 31, 2022 |
EXHIBIT 99.1 Nutriband issued full US patent for its AVERSA? abuse deterrent transdermal platform by United States Patent and Trademark Office. ORLANDO, Fla., January 28, 2022 ? Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced the receipt of an Issue Notification from the United States Patent and Trademark Office (USPTO) for its United States patent entitled, ?Abuse and Misuse Deterrent |
|
| January 27, 2022 |
Amended and Restated By-Laws adopted January 21, 2022.(12) EXHIBIT 3.2A As Adopted by the Board of Directors on January 21, 2022 AMENDED AND RESTATED BY-LAWS OF NUTRIBAND INC. ARTICLE I ? OFFICES The registered office of the Corporation in the State of Nevada shall be located at such location as shall be determined by the Board of Directors, and it may be changed from time to time by the Board of Directors. The Corporation may also maintain offices at suc |
|
| January 27, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2022 Nutriband, Inc. |
|
| January 27, 2022 |
Employment Agreement effective February 1, 2022, between the Company and Gerald Goodman.(12) EXHIBIT 10.29 Employment agreement NUTRIBAND INC. THIS EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 1, 2022 (?Effective Date?), by and between GERALD GOODMAN, of 7 Briarwood Road, Rumson NJ 07760 (?Executive?) and NUTRIBAND Inc., a Nevada corporation (the ?Company?). PREAMBLE WHEREAS, the Board of Directors of the Company recognizes Executive?s previous and potential contribution to t |
|
| January 27, 2022 |
EXHIBIT 99.1 Nutriband Inc. expands product development pipeline for its AVERSA? platform abuse deterrent technology ORLANDO, Fla., January 18, 2022 ? Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) announced an expanded product development pipeline for its proprietary AVERSA? abuse deterrent transdermal technology. The AVERSA abuse deterrent technology platform can be applied to any transdermal patch |
|
| January 27, 2022 |
Employment Agreement effective February 1, 2022, between the Company and Gareth Sheridan.(12) EXHIBIT 10.27 Employment agreement NUTRIBAND INC. THIS EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 1, 2022 (?Effective Date?), by and between GARETH SHERIDAN of 333 Fairway Blvd., Panama City Beach, FL, 32407, (?Executive?) and NUTRIBAND Inc., a Nevada corporation (the ?Company?). PREAMBLE WHEREAS, the Board of Directors of the Company recognizes Executive?s previous and potential co |
|
| January 27, 2022 |
Employment Agreement effective February 1, 2022, between the Company and Serguei Melnik.(12) EXHIBIT 10.28 Employment agreement NUTRIBAND INC. THIS EMPLOYMENT AGREEMENT (?Agreement?) is made as of February 1, 2022 (?Effective Date?), by and between SERGUEI MELNIK of 121 South Orange Ave., Suite 1500, Orlando, Florida 32801 (?Executive?), and NUTRIBAND Inc., a Nevada corporation (the ?Company?). PREAMBLE WHEREAS, the Board of Directors of the Company recognizes Executive?s previous and pot |
|
| January 10, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 Nutriband Inc. |
|
| January 10, 2022 |
EXHIBIT 99.1 Nutriband Inc. and Kindeva Drug Delivery sign feasibility agreement to develop AVERSA? Fentanyl, an abuse deterrent fentanyl patch ORLANDO, Fla., January 10, 2022 ? Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced the signing of a feasibility agreement with Kindeva Drug Delivery to develop Nutriband?s lead product, AVERSA? Fentanyl, based on its proprietary AVERSA? abuse de |
|
| January 3, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-259833 PROSPECTUS SUPPLEMENT No. 3 January 3, 2022 (To Prospectus dated October 1, 2021) NUTRIBAND INC. 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock This prospectus supplement further supplements and updates the prospectus dated October 1, 2021, relating to our offering throug |
|
| January 3, 2022 |
Financial Statements and Exhibits, Regulation FD Disclosure SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2021 Nutriband, Inc. |
|
| January 3, 2022 |
Exhibit 99.1 Nutriband Inc. Issued Full Patent From Korean Intellectual Property Office (KIPO) for its ‘Abuse and Misuse Deterrent Transdermal System’ Application ORLANDO, Fla., Dec 31, 2021 – Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), has announced that the Korean Intellectual Property Office has fully issued its patent titled ‘Abuse and Misuse Deterrent Transdermal System’ which is related t |
|
| December 30, 2021 |
Nutriband Inc. Announces $1 Million Share Repurchase Authorization Exhibit 99.1 Nutriband Inc. Announces $1 Million Share Repurchase Authorization ORLANDO, Fla., December 29, 2021 ? Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of December 29, 2021, the Company had 7,773,962 shares of common stock outstanding. About Nutriband Inc. We are primarily engaged in the develop |
|
| December 30, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2021 Nutriband, Inc. |
|
| December 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact nam |
|
| December 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| November 15, 2021 |
141,828 Shares of Common Stock Nutriband Inc. Trading symbol for the common stock: NTRB Filed Pursuant to Rule 424(b)(3) Registration No. 333-237724 141,828 Shares of Common Stock Nutriband Inc. Trading symbol for the common stock: NTRB This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 141,828 shares of our common stock, of which 46,828 shares were issued in recent private placements, and 95,000 shares relate to the resale of sha |
|
| November 12, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-259833 PROSPECTUS SUPPLEMENT November 12, 2021 (To Prospectus dated October 1, 2021) NUTRIBAND INC. 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock This prospectus supplement further supplements and updates the prospectus dated October 1, 2021, relating to our offering through un |
|
| November 5, 2021 |
2021 Employee Stock Option Plan.(11) Exhibit 10.1 NUTRIBAND INC. 2021 EMPLOYEE STOCK OPTION PLAN 1. Purpose The proper execution of the duties and responsibilities of the executives, directors, and key employees of Nutriband Inc. (the ?Corporation?), as well as consultants to the Corporation, is a vital factor in the continued growth and success of the Corporation. Toward this end, it is necessary to attract and retain effective and |
|
| November 5, 2021 |
As filed with the Securities and Exchange Commission on November 5, 2021 As filed with the Securities and Exchange Commission on November 5, 2021 Registration No. |
|
| November 5, 2021 |
Form of Stock Option Grant Notice.(11) Exhibit 10.2 NUTRIBAND INC. 2021 EMPLOYEE STOCK OPTION PLAN OPTION AWARD AGREEMENT You have been granted an option to purchase Common Stock of NUTRIBAND INC., a Nevada corporation (the ?Company?), as follows: Date of Grant: Exercise Price Per Share: Total Number of Shares: Total Exercise Price: Type of Option: Expiration Date: Vesting Commencement Date: Vesting/Exercise Schedule: So long as your C |
|
| October 21, 2021 |
As filed with the Securities and Exchange Commission on October 21, 2021 As filed with the Securities and Exchange Commission on October 21, 2021 Registration No. |
|
| October 12, 2021 |
EX-10.26 2 ea148731ex10-26nutriband.htm SERVICES AGREEMENT OCTOBER 4, 2021, BY AND BETWEEN ACTIVE INTELLIGENCE, LLC AND DIOMICS CORPORATION Exhibit 10.26 ACTIVE INTELLIGENCE, LLC SERVICES AGREEMENT This Services Agreement (this “Agreement”) is made as of October 4th, 2021 (the “Effective Date”) by and between Active Intelligence, LLC, a North Carolina based liability company, (“Active Intelligence |
|
| October 12, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2021 Nutriband, Inc. |
|
| October 8, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2021 Nutriband, Inc. |
|
| October 5, 2021 |
Filed Pursuant to Rule 424(b)4 Registration 333-259833 PROSPECTUS 1,056,000 Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock Nutriband Inc. |
|
| October 1, 2021 |
Form of Warrant Agent Agreement(9). Exhibit 4.13 WARRANT AGENT AGREEMENT This Warrant Agent Agreement (?Warrant Agreement?) is made as of September 30, 2020, by and between Nutriband Inc. (the ?Company?), and American Stock Transfer & Trust Company, LLC (the ?Warrant Agent?). WHEREAS, the Company is engaged in a public offering (the ?Public Offering?) of 1,056,000 shares of common stock, par value $0.001 per share (the ?Common Stock |
|
| October 1, 2021 |
Form of Underwriting Agreement, filed herewith. EX-1.1 2 ea148206ex1-1nutriband.htm FORM OF UNDERWRITING AGREEMENT Exhibit 1.1 NUTRIBAND, INC. UNDERWRITING AGREEMENT [*] Units Consisting of [*] Shares of Common Stock And [*] Warrants to Purchase [*] Shares of Common Stock [*], 2021 WallachBeth Capital, LLC Harborside Financial Plaza 5 185 Hudson St., Suite 1410 Jersey City, NJ 07311 As Representative of the Several Underwriters Named on Schedul |
|
| October 1, 2021 |
As filed with the Securities and Exchange Commission on October 1, 2021 As filed with the Securities and Exchange Commission on October 1, 2021 Registration No. |
|
| October 1, 2021 |
Form of Underwriter’s Warrant(9). Exhibit 4.12 COMMON STOCK PURCHASE WARRANT NUTRIBAND INC. Warrant Shares: CUSIP: ISIN: THIS COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [ ] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the initial exercise date first set forth above (the ?I |
|
| October 1, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2021 Nutriband, Inc. |
|
| September 30, 2021 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 September 30, 2021 NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 September 30, 2021 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Timothy Buchmiller, Staff Attorney Re: Nutriband Inc. Registration Statement on Form S-1 File No. 333-259833 REQUEST FOR ACCELERATION OF EFFECTIVENESS Dear Mr. Buchmiller: Pursuant to Rule 46 |
|
| September 30, 2021 |
CORRESP 1 filename1.htm WallachBeth Capital, LLC Harborside Financial Plaza 5 185 Hudson St., Suite 1410 Jersey City, NJ 07311 September 30, 2021 VIA EDGAR CORRESPONDENCE Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Timothy Buchmiller, Staff Attorney Re: Nutriband Inc. Registration Statement on Form S-1 File No. 333-259833 De |
|
| September 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Nutriband Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 81-1118176 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 121 South Orange Ave., Suite 15 |
|
| September 29, 2021 |
As filed with the Securities and Exchange Commission on September 29, 2021 As filed with the Securities and Exchange Commission on September 29, 2021 Registration No. |
|
| September 27, 2021 |
As filed with the Securities and Exchange Commission on September 27, 2021 As filed with the Securities and Exchange Commission on September 27, 2021 Registration No. |
|
| September 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name o |
|
| September 1, 2021 |
Exhibit 10.25 AMENDMENT NO. 1 TO PURCHASE AGREEMENT AND PROMISSORY NOTE THIS Amendment No. 1 to Purchase Agreement is entered into as of August 31, 2021, by and among by and among NUTRIBAND INC., a Nevada corporation (?Nutriband?), POCONO PHARMACEUTICALS, INC., a Delaware corporation (?NBI Sub?), and POCONO COATED PRODUCTS, LLC, a Pennsylvania limited liability company (?Pocono?) and ACTIVE INTELL |
|
| September 1, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2021 Nutriband Inc. |
|
| June 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| April 7, 2021 |
As filed with the Securities and Exchange Commission on , 2021 As confidentially submitted to the Securities and Exchange Commission on APRIL 7, 2021. |
|
| April 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2021 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. (Exact name of reg |
|
| March 11, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2020 Nutriband Inc. |
|
| March 11, 2021 |
License Agreement, dated December 9, 2020, between the Company and Rambam Med-Tech Ltd.(8) Exhibit 10.22 |
|
| March 11, 2021 |
Stock Purchase Agreement, dated December 7, 2020, between the Company and BPM Inno Ltd.(8) EX-10.24 4 ea137408ex10-24nutriband.htm STOCK PURCHASE AGREEMENT, DATED DECEMBER 7, 2020, BETWEEN THE COMPANY AND BPM INNO LTD Exhibit 10.24 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
|
| March 11, 2021 |
Distribution Agreement, dated March 26, 2021, between the Company and BPM Inno Ltd.(8) Exhibit 10.23 |
|
| February 1, 2021 |
As filed with the Securities and Exchange Commission on , 2021 As confidentially submitted to the Securities and Exchange Commission on JANUARY 29, 2021. |
|
| January 22, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No. 2 to FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 Nutriband, Inc. Nevada 000-55654 81-1118176 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 121 S. Oran |
|
| January 21, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 Nutriband, Inc. |
|
| January 21, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 Nutriband, Inc. Nevada 000-55654 81-1118176 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 121 S. Oran |
|
| January 19, 2021 |
141,828 Shares of Common Stock Nutriband Inc. OTCQB trading symbol for the common stock: NTRB Filed Pursuant to Rule 424(b)(3) Registration No. 333-237724 141,828 Shares of Common Stock Nutriband Inc. OTCQB trading symbol for the common stock: NTRB This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 141,828 shares of our common stock, of which 46,828 shares were issued in recent private placements, and 95,000 shares relate to the resale |
|
| January 12, 2021 |
Financial Statements and Exhibits - AMENDMENT NO. 1 TO FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 Nutriband Inc. |
|
| December 15, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact nam |
|
| October 9, 2020 |
- DEFINITIVE INFORMATION STATEMENT SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement NUTRIBAND INC. |
|
| September 23, 2020 |
141,828 Shares of Common Stock Nutriband Inc. OTCQB trading symbol for the common stock: NTRB Filed Pursuant to Rule 424(b)(3) Registration No. 333-237724 141,828 Shares of Common Stock Nutriband Inc. OTCQB trading symbol for the common stock: NTRB This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 141,828 shares of our common stock, of which 46,828 shares were issued in recent private placements, and 95,000 shares relate to the resale |
|
| September 11, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name o |
|
| September 4, 2020 |
Security Agreement, between the Company and Pocono Coated Products, LLC.(7) EXHIBIT 10.20 Execution SECURITY Agreement This Security Agreement (this “Agreement”), dated August 31, 2020, is by and between NUTRIBAND, INC., a Nevada corporation (the “Debtor”), and POCONO COATED PRODUCTS, LLC, a Pennsylvania limited liability company (“Secured Party”). Debtor and Secured Party may be referred to herein collectively as the “Parties” or individually as a “Party.” RECITALS WHERE |
|
| September 4, 2020 |
EXHIBIT 10.19 EXECUTION VERSION PURCHASE AGREEMENT This Purchase Agreement, dated this 31st day of August, 2020, by and among NUTRIBAND INC., a Nevada corporation (“Nutriband”), POCONO PHARMACEUTICALS, INC., a Delaware corporation (“NBI Sub”), and POCONO COATED PRODUCTS, LLC, a Pennsylvania limited liability company (“Pocono”) and POCONO PCP SUB, INC., a Delaware corporation (“PCP Sub”). WHEREAS, |
|
| September 4, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 Nutriband, Inc. |
|
| September 4, 2020 |
Promissory Note Issued by the Company on August 31, 2020 to Pocono Coated Products, LLC.(7) EXHIBIT 10.21 NUTRIBAND INC. PROMISSORY NOTE $1,500,000 August 31, 2020 FOR VALUE RECEIVED, NUTRIBAND INC., a Nevada corporation (hereinafter called “Borrower” or the “Company”), hereby promises to pay to POCONO COATED PRODUCTS, LLC, a Pennsylvania limited liability company (“Holder”), or order, the sum of One Million Five Hundred Thousand ($1,500,000) Dollars, with interest accruing at the annual |
|
| July 6, 2020 |
141,828 Shares of Common Stock Nutriband Inc. OTCQB trading symbol for the common stock: NTRB Filed Pursuant to Rule 424(b)(3) Registration No. 333-237724 141,828 Shares of Common Stock Nutriband Inc. OTCQB trading symbol for the common stock: NTRB This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 141,828 shares of our common stock, of which 46,828 shares were issued in recent private placements, and 95,000 shares relate to the resale |
|
| June 4, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| June 2, 2020 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 June 2, 2020 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Timothy Buchmiller, Staff Attorney Re: Nutriband Inc. Registration Statement on Form S-1 File No. 333-237724 REQUEST FOR ACCELERATION OF EFFECTIVENESS Dear Mr. Buchmiller: Pursuant to Rule 461 unde |
|
| May 28, 2020 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 27, 2020 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated May 22, 2020 Amendment No. 1 to Registration Statement on Form S-1 Filed May 19, 2020 File No. 333-237724 Dear Sir/Madam: Please find below responses to certain questions raised by the staff of the Securities and |
|
| May 27, 2020 |
As filed with the Securities and Exchange Commission on May 27, 2020 Registration No. |
|
| May 21, 2020 |
NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 May 18, 2020 Securities and Exchange Commission Washington, D.C. 20549 RE: Nutriband Inc. SEC Comment Letter dated May 13, 2020 Registration Statement on Form S-1 Filed April 16, 2020 File No. 333-237724 Dear Sir/Madam: Please find below responses to certain questions raised by the staff of the Securities and Exchange Commissi |
|
| May 19, 2020 |
Employment Agreement, dated January 1, 2018, between Sean Gallagher and the Company.(5) Exhibit 10.18 NUTRIBAND INC. (NTRB) EXECUTIVE EMPLOYMENT AGREEMENT THIS AGREEMENT made effective as of January 1st 2018 BETWEEN: NUTRIBAND INC. 309 Celtic Ct, Oviedo FL, 32765 (Corporation) And, SEAN GALLAGHER 18 Priory Avenue, Eden Gate, Delgany, County Wicklow, A63 FR63, Ireland (Executive) WHEREAS: A. The Corporation is in the business of transdermal technology in relation to drugs, diagnostics |
|
| May 19, 2020 |
As filed with the Securities and Exchange Commission on May 19, 2020 Registration No. |
|
| May 19, 2020 |
Exhibit 4.10 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| May 19, 2020 |
Employment Agreement, dated April 23, 2019, between Gareth Sheridan and the Company.(5) Exhibit 10.15 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 23rd day of April, 2019, by and between Gareth Sheridan, an individual with an address at 1588S 1300E Salt Lake City, UT 84105 (“Executive”) and Nutriband Inc., a Nevada corporation with an address at 121 South Orange Ave., Suite 1500, Orlando, FL (the “Company”). W I T N E S S E T H: WHEREAS, Executive is a party to an employment a |
|
| May 19, 2020 |
Employment Agreement, dated April 23, 2019, between Serguei Melnik and the Company.(5) Exhibit 10.16 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 23rd day of April, 2019, by and between Serguei Melnik, an individual with an address at 309 Celtic Ct., Oviedo, FL 32765 (“Executive”) and Nutriband Inc., a Nevada corporation with an address at 121 South Orange Ave., Suite 1500, Orlando, FL (the “Company”). W I T N E S S E T H: WHEREAS, Executive is a party to an employment agreem |
|
| May 19, 2020 |
Employment Agreement, dated February 19, 2019, between Jeffrey Patrick and the Company.(5) Exhibit 10.17 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 19th day of February, 2019, by and among Jeffrey T. Patrick Pharm.D., an individual with an address at 4047 Prince George Ln, New Albany, OH 43054 (“Executive”) and Nutriband Inc., a Nevada corporation with offices at 121 South Orange Ave., Suite 1500, Orlando, Florida 32801 (the “Company”). W I T N E S S E T H: WHEREAS, the Company |
|
| April 16, 2020 |
NTRB / Nutriband Inc S-1 - Registration Statement - REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on April 16, 2020 Registration No. |
|
| April 16, 2020 |
Exhibit 4.10 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| April 14, 2020 |
NTRB / Nutriband Inc 10-K - Annual Report - ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-55654 NUTRIBAND INC. (Exact name of regi |
|
| April 3, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2020 Nutriband Inc. |
|
| March 20, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2020 Nutriband Inc. |
|
| March 20, 2020 |
Nutriband Inc. receives patent protection from Australia, Russia and Mexico. Exhibit 99.1 Nutriband Inc. receives patent protection from Australia, Russia and Mexico. ORLANDO, Fla., March 18, 2020 – Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the “Company”) has received a notice of grant from patent offices in Australia and Russia and a notice of allowance from Mexico’s patent office for the ‘Abuse and Misuse Deterrent Transdermal Systems’ patent application filed |
|
| March 9, 2020 |
NTRB / Nutriband Inc RW - - WITHDRAWAL OF REGISTRATION STATEMENT NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 March 9, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Nutriband Inc. Registration Statement on Form S-1 (File No. 333-232370) Request for Withdrawal Ladies and Gentlemen: Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amen |
|
| February 21, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2020 Nutriband Inc. |
|
| January 27, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2020 Nutriband Inc. |
|
| January 27, 2020 |
Exhibit 3.1 |
|
| January 9, 2020 |
NTRB / Nutriband Inc DEF 14A - - DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| December 26, 2019 |
NTRB / Nutriband Inc PRE 14A - - PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| December 13, 2019 |
Form of warrant agent agreement(6) Exhibit 4.1 WARRANT AGENT AGREEMENT THIS WARRANT AGENT AGREEMENT (this “Agreement”) is dated December [ ], 2019, between Nutriband Inc., a Nevada corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, acting as warrant agent (the “Warrant Agent”). WHEREAS, the Company proposes to issue series A common stock purchase warrants (the “Warrants”) to acquire up to 359,375 of comm |
|
| December 13, 2019 |
NTRB / Nutriband Inc S-1/A - - AMENDMENT NO. 8 TO FORM S-1 As filed with the Securities and Exchange Commission on December 13, 2019 Registration No. |
|
| December 12, 2019 |
NTRB / Nutriband Inc 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact nam |
|
| December 3, 2019 |
Form of warrant certificate(5) Exhibit 4.2 EXERCISABLE ON OR AFTER [ ], 2019 AND UNTIL 5:00 P.M. (NEW YORK TIME) ON THE EXPIRATION DATE CUSIP: No. Warrants to Purchase [] Shares Warrant Certificate SERIES A WARRANTS TO PURCHASE COMMON STOCK OF NUTRIBAND INC. This Warrant Certificate certifies that [], or registered assigns, is the registered holder of Warrants (the “Warrants”) to acquire from Nutriband Inc., a Nevada corporatio |
|
| December 3, 2019 |
NTRB / Nutriband Inc S-1/A - - REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on December 3, 2019 Registration No. |
|
| December 3, 2019 |
Subsidiaries of the Company(5) Exhibit 21.1 Subsidiaries of the Registrant 4P Therapeutics LLC, a Delaware limited liability company Nutriband Limited, an Ireland corporation |
|
| December 3, 2019 |
Form of underwriting agreement(5) Exhibit 1.1 NUTRIBAND INC. UNDERWRITING AGREEMENT December , 2019 WallachBeth Capital LLC Harborside Financial Center Plaza 5 185 Hudson Street, Ste 1410 Jersey City, NJ 07311 As Representative of the Several Underwriters Named on Schedule I hereto Ladies and Gentlemen: The undersigned, Nutriband Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliat |
|
| December 3, 2019 |
Form of warrant agent agreement(6) Exhibit 4.1 WARRANT AGENT AGREEMENT THIS WARRANT AGENT AGREEMENT (this “Agreement”) is dated December [ ], 2019, between Nutriband Inc., a Nevada corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, acting as warrant agent (the “Warrant Agent”). WHEREAS, the Company proposes to issue series A common stock purchase warrants (the “Warrants”) to acquire up to 359,375 of comm |
|
| November 26, 2019 |
2 3 4 5 6 7 8 9 10 11 12 13 |
|
| November 25, 2019 |
NTRB / Nutriband Inc S-1/A - - AMENDMENT NO. 6 TO FORM S-1 As filed with the Securities and Exchange Commission on November 25, 2019 Registration No. |
|
| November 25, 2019 |
Form of Warrant Agent Agreement(6) Exhibit 4.1 WARRANT AGENT AGREEMENT THIS WARRANT AGENT AGREEMENT (this “Agreement”) is dated December [ ], 2019, between Nutriband Inc., a Nevada corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, acting as warrant agent (the “Warrant Agent”). WHEREAS, the Company proposes to issue series A common stock purchase warrants (the “Warrants”) to acquire up to 359,375 of comm |
|
| November 25, 2019 |
Form of warrant certificate(6) Exhibit 4.2 EXERCISABLE ON OR AFTER [ ], 2019 AND UNTIL 5:00 P.M. (NEW YORK TIME) ON THE EXPIRATION DATE CUSIP: No. Warrants to Purchase [] Shares Warrant Certificate SERIES A WARRANTS TO PURCHASE COMMON STOCK OF NUTRIBAND INC. This Warrant Certificate certifies that [], or registered assigns, is the registered holder of Warrants (the “Warrants”) to acquire from Nutriband Inc., a Nevada corporatio |
|
| November 15, 2019 |
NTRB / Nutriband Inc S-1/A - - AMENDMENT TO FORM S-1 As filed with the Securities and Exchange Commission on November 15, 2019 Registration No. |
|
| November 4, 2019 |
Form of convertible 6% promissory note issued pursuant to Exhibit 4.3(6) EX-4.2 3 f8k103019ex4-2nutriband.htm FORM OF CONVERTIBLE 6% PROMISSORY NOTE Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR |
|
| November 4, 2019 |
Exhibit 4.1 [Conformed Copy] SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 29, 2019 (the “Effective Date”), by and between NUTRIBAND INC., a Nevada corporation, with headquarters located at 121 South Orange Ave., Suite 1500, Orlando, FL 32801 (the “Company”), and each buyer identified on the signature pages hereto (each, including it succes |
|
| November 4, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2019 Nutriband Inc. |
|
| November 4, 2019 |
EX-4.3 4 f8k103019ex4-3nutriband.htm FORM OF WARRANT Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OF |
|
| September 17, 2019 |
Form of underwriting agreement Exhibit 1.1 NUTRIBAND INC. UNDERWRITING AGREEMENT September , 2019 Aegis Capital Corp. 810 Seventh Avenue, 18th Floor New York, NY 10019 As Representative of the Several Underwriters Named on Schedule I hereto Ladies and Gentlemen: The undersigned, Nutriband Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all |
|
| September 17, 2019 |
Form of Warrant Agent Agreement(6) Exhibit 4.1 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of , 2019 (the “Issuance Date”) between Nutriband Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), |
|
| September 17, 2019 |
Exhibit 4.2 COMMON STOCK PURCHASE WARRANT NUTRIBAND INC. Warrant Shares: [] Initial Exercise Date: [], 2019 THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercis |
|
| September 17, 2019 |
NTRB / Nutriband Inc S-1/A - - REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on September 17, 2019 Registration No. |
|
| September 12, 2019 |
NTRB / Nutriband Inc 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name o |
|
| August 30, 2019 |
NTRB / Nutriband Inc S-1/A - - AMENDMENT NO.3 TO FORM S-1 As filed with the Securities and Exchange Commission on August 30, 2019 Registration No. |
|
| August 30, 2019 |
Exhibit 14.1 Nutriband Inc. Code of Ethics Preface The honesty, integrity, ethics, respect for others and sound judgment displayed by directors, principal executives and financial officers of Nutriband Inc. (the “Company”) set the tone for business conduct, and are fundamental to the proper functioning, reputation and success of the Company. This Code of Ethics is composed of expressions of good b |
|
| August 30, 2019 |
EX-4.3 2 fs12019a3ex4-3nutriband.htm PRE FUNDED COMMON STOCK PURCHASE WARRANT Exhibit 4.3 PRE-FUNDED COMMON STOCK PURCHASE WARRANT NUTRIBAND INC. Warrant Shares: [] Initial Exercise Date: [], 2019 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and |
|
| August 30, 2019 |
Nominating and Corporate Governance Committee Charter(5) EX-99.3 5 fs12019a3ex99-3nutriband.htm NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER Exhibit 99.3 Nutriband Inc. Nominating and Corporate Governance Committee Charter Adopted August 1, 2019 Purpose The Nominating and Corporate Governance Committee (the “Committee”) is created by the Board of Directors (the “Board”) of Nutriband Inc. (the “Company”) to: ● review and evaluate the size, compo |
|
| August 16, 2019 |
Exhibit 4.3 PRE-FUNDED COMMON STOCK PURCHASE WARRANT NUTRIBAND INC. Warrant Shares: [] Initial Exercise Date: [], 2019 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof |
|
| August 16, 2019 |
Form of Warrant Agent Agreement(5) Exhibit 4.1 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of , 2019 (the “Issuance Date”) between Nutriband Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), |
|
| August 16, 2019 |
NTRB / Nutriband Inc S-1/A - - AMENDMENT TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on August 16, 2019 Registration No. |
|
| August 16, 2019 |
Exhibit 4.2 COMMON STOCK PURCHASE WARRANT NUTRIBAND INC. Warrant Shares: [] Initial Exercise Date: [], 2019 THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercis |
|
| July 25, 2019 |
NTRB / Nutriband Inc S-1/A - - As filed with the Securities and Exchange Commission on July 25, 2019 Registration No. |
|
| July 22, 2019 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2019 Nutriband Inc. |
|
| June 26, 2019 |
Employment agreement dated April 23, 2019 between the Company and Gareth Sheridan(5) Exhibit 10.8 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 23rd day of April, 2019, by and between Gareth Sheridan, an individual with an address at 1588S 1300E Salt Lake City, UT 84105 (“Executive”) and Nutriband Inc., a Nevada corporation with an address at 121 South Orange Ave., Suite 1500, Orlando, FL (the “Company”). W I T N E S S E T H: WHEREAS, Executive is a party to an employment ag |
|
| June 26, 2019 |
Extension agreement dated May 26, 2019 between the Company and EMI-Korea (Best Choice), Inc.(5) Exhibit 10.10 May 26, 2019 EMI-Korea (Best Choice), Inc. [address per agreement] Attention: Kim Nam Hun Reference is made to the Exclusive Master Distribution Agreement (the “Agreement”) dated April 13, 2018 between EMI-Korea (Best Choice), Inc. (“Best Choice”) and Nutriband Inc. (“Nutriband”). Nutriband and Best Choice have worked together to seek to build the Nutriband brand in Korea and we appr |
|
| June 26, 2019 |
Agreement dated July 31, 2018 between the Company and Srinvas Nalamachu.(5) Exhibit 10.7 NUTRIBAND INC. (NTRB) ADVISORY BOARD AGREEMENT THIS OFFER made effective as of July 31, 2018 BETWEEN: NUTRIBAND INC. 309 Celtic Ct, Oviedo FL, 32765 (Corporation) And, DR. SRINIVAS (SRI) NALAMACHU, MDDr. WHEREAS: A. The Corporation is in the business of transdermal technology in relation to drugs, consumer products, research and development B. Dr. Nalamachu is being appointed by the C |
|
| June 26, 2019 |
Articles of incorporation, as amended(5) Exhibit 3.1 |
|
| June 26, 2019 |
Employment agreement dated April 23, 2019 between the Company and Serguei Melnik(5) Exhibit 10.9 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 23rd day of April, 2019, by and between Serguei Melnik, an individual with an address at 309 Celtic Ct., Oviedo, FL 32765 (“Executive”) and Nutriband Inc., a Nevada corporation with an address at 121 South Orange Ave., Suite 1500, Orlando, FL (the “Company”). W I T N E S S E T H: WHEREAS, Executive is a party to an employment agreeme |
|
| June 26, 2019 |
NTRB / Nutriband Inc S-1 - Registration Statement - As filed with the Securities and Exchange Commission on June 26, 2019 Registration No. |
|
| June 26, 2019 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2019 Nutriband Inc. |
|
| June 18, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2019 Nutriband Inc. Nevada 000-55654 81-1118176 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 121 South Orang |
|
| June 18, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2019 Nutriband Inc. |
|
| June 13, 2019 |
NTRB / Nutriband Inc 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-55654 NUTRIBAND INC. (Exact name |
|
| April 30, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2019 Nutriband Inc. |
|
| April 30, 2019 |
Nutriband Inc.’s Abuse Deterrent Transdermal Technology Patent Granted by Japan’s Patent Office Exhibit 99.1 Nutriband Inc.’s Abuse Deterrent Transdermal Technology Patent Granted by Japan’s Patent Office ORLANDO, Fla., April 23, 2019 – Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the “Company”), announced today that the Japan Patent Office has granted full patent protection for Japanese Patent Application entitled, “Abuse and Misuse Deterrent Transdermal System” submitted by its subs |
|
| April 25, 2019 |
NUTRIBAND INC. ADVISORY BOARD AGREEMENT Exhibit 10.8 NUTRIBAND INC. (NTRB) ADVISORY BOARD AGREEMENT THIS OFFER made effective as of July 31, 2018 BETWEEN: NUTRIBAND INC. 309 Celtic Ct, Oviedo FL, 32765 (Corporation) And, DR. SRINIVAS (SRI) NALAMACHU, MDDr. WHEREAS: A. The Corporation is in the business of transdermal technology in relation to drugs, consumer products, research and development B. Dr. Nalamachu is being appointed by the C |
|
| April 25, 2019 |
Exhibit 10.10 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 23rd day of April, 2019, by and between Serguei Melnik, an individual with an address at 309 Celtic Ct., Oviedo, FL 32765 (“Executive”) and Nutriband Inc., a Nevada corporation with an address at 121 South Orange Ave., Suite 1500, Orlando, FL (the “Company”). W I T N E S S E T H: WHEREAS, Executive is a party to an employment agreem |
|
| April 25, 2019 |
NTRB / Nutriband Inc DRS/A - - As confidentially submitted to the U. S. Securities and Exchange Commission on April , 2019 pursuant to the Jumpstart Our Business Startups Act of 2012 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 2 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nutriband Inc. (Exact name of registrant as specified in its charter) |
|
| April 25, 2019 |
Exhibit 10.9 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made the 23rd day of April, 2019, by and between Gareth Sheridan, an individual with an address at 1588S 1300E Salt Lake City, UT 84105 (“Executive”) and Nutriband Inc., a Nevada corporation with an address at 121 South Orange Ave., Suite 1500, Orlando, FL (the “Company”). W I T N E S S E T H: WHEREAS, Executive is a party to an employment ag |
|
| April 19, 2019 |
Exhibit 10.5 EXCLUSIVE MASTER DISTRIBUTION AGREEMENT BETWEEN NUTRIBAND, INC. AND BEST CHOICE (EMI), INC. THIS EXCLUSIVE MASTER DISTRIBUTION AGREEMENT (this “Agreement”) is made as of the last date of signature (“Effective Date”), by and between Nutriband, INC., a Nevada Corporation, having its principal office located at Celtic Ct, 309 Oviedo, FL 32765, U.S.A, (hereinafter referred to as the “COMP |
|
| April 19, 2019 |
Exhibit 99.1 NUTRIBAND INC. AUDIT COMMITTEE CHARTER 1. STATUS The Audit Committee (the “Committee”) is a committee of the Board of Directors (the “Board”) of Nutriband Inc. (the “Company”). 2. PURPOSE The Committee is appointed by the Board for the primary purposes of: ● Performing the Board’s oversight responsibilities as they relate to the Company’s accounting policies and internal controls, fin |
|
| April 19, 2019 |
Form of agreement with independent directors.(4) Exhibit 10.4 NUTRIBAND, INC. 121 S. Orange Ave., Suite 1500 Orlando Florida 32801 August 22, 2018 [name and address] Re: Service as Independent Director Dear: Nutriband, Inc., a Nevada corporation (the “Company”), is pleased that you have agreed to serve as a member of its Board of Directors (the “Board”). We believe your background and experience will be a significant asset to the Company, and we |
|
| April 19, 2019 |
Option agreement between the Company and Jeffrey T. Patrick* EX-10.6 4 f10k2019ex10-6nutribandinc.htm OPTION AGREEMENT BETWEEN THE COMPANY AND JEFFREY T. PATRICK Exhibit 10.6 INSTRUMENT OF NONQUALIFIED STOCK OPTION GRANT Instrument of Grant issued as of this 19th of February, 2019, from Nutriband Inc., a Nevada corporation, with offices at 121 South Orange Ave., Suite 1500, Orlando, FL 32801 (the “Company”), to Jeffrey T. Patrick (the “Option Holder”). W I |
